Incyte Corp. Share Price
NASDAQ: INCY | Large CapIncyte Corp. Stock Performance
Incyte Corp. Share Price Today
As of 19 September 2026, Incyte Corp.'s share price is $125.41. The stock opened at $128.53, compared to its previous close of $127.65. During today's trading session, Incyte Corp.'s share price traded between $125.25 and $128.72, with an average price of $126.99. Over the past 52 weeks, the stock has recorded a high of $132.59 and a low of $81.12. In terms of performance, Incyte Corp.'s share price has risen by 33.24% over the last six months and is up 47.87% on a year-on-year basis.
Incyte Corp. Share Price Chart
Incyte Corp. Quarterly Profit & Loss
All figures in USD
Incyte Corp. Annual Profit & Loss
All figures in USD
About Incyte Corp.
Incyte Corporation, headquartered in Wilmington, Delaware, is a biopharmaceutical company focused on discovering and developing small molecule drugs for oncology and inflammation. Its flagship product, Jakafi, treats rare blood cancers. Incyte invests heavily in research and has multiple collaborations with global pharmaceutical companies.
Incyte Corp. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $125.08 | $125.28 | -1.91% |
Aug 2026 | $120.49 | $127.72 | +6.91% |
Jul 2026 | $114.70 | $119.47 | +5.44% |
Jun 2026 | $96.33 | $113.31 | +17.20% |
May 2026 | $95.22 | $96.68 | +1.36% |
Apr 2026 | $94.75 | $95.39 | +1.34% |
Mar 2026 | $99.91 | $94.13 | -7.01% |
Feb 2026 | $99.55 | $101.22 | +1.20% |
Jan 2026 | $98.51 | $100.02 | +1.25% |
Dec 2025 | $103.62 | $98.79 | -5.46% |
Nov 2025 | $93.95 | $104.50 | +11.80% |
Oct 2025 | $85.29 | $93.47 | +10.21% |